Adello Biologics Revenue and Competitors
Estimated Revenue & Valuation
- Adello Biologics's estimated annual revenue is currently $3.6M per year.
- Adello Biologics's estimated revenue per employee is $201,000
Employee Data
- Adello Biologics has 18 Employees.
- Adello Biologics grew their employee count by -14% last year.
Adello Biologics's People
Name | Title | Email/Phone |
---|
Adello Biologics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $6.6M | 33 | 32% | N/A | N/A |
#2 | $38M | 189 | 6% | N/A | N/A |
#3 | $6.6M | 33 | 22% | N/A | N/A |
#4 | $4180M | 15242 | 1% | $550M | N/A |
#5 | $17.5M | 87 | 50% | N/A | N/A |
#6 | $6.7M | 125 | -37% | $199.6M | N/A |
#7 | $10.9M | 54 | 15% | N/A | N/A |
#8 | $15.3M | 76 | 33% | N/A | N/A |
#9 | $128.6M | 640 | 16% | N/A | N/A |
#10 | $18.7M | 93 | 21% | N/A | N/A |
What Is Adello Biologics?
Adello is a privately held, U.S.-based biotechnology company that leads with science to accelerate development and drive manufacturing efficiency. The company's aim is to provide high-quality, affordable biosimilars to patients worldwide. Headquartered in Piscataway, NJ and driven by a team of highly skilled industry veterans, Adello is advancing a strategic pipeline of proteins and complex monoclonal antibodies with lead candidates in oncology and immunology. For more information, visit Adellobio.com.
keywords:N/AN/A
Total Funding
18
Number of Employees
$3.6M
Revenue (est)
-14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.6M | 18 | N/A | N/A |
#2 | $1.4M | 18 | -5% | N/A |
#3 | $1.6M | 18 | 0% | N/A |
#4 | $1.7M | 19 | 6% | N/A |
#5 | $3.4M | 20 | -9% | N/A |